Finnrick - Ensuring a Safer and More Transparent Supply Chain
Baohua Dongnuo Biotechnology BHD

Baohua Dongnuo Biotechnology BHD

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Baohua Dongnuo Biotechnology BHD between 11 Aug 2025 and 20 Feb 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
Tentative Rating
Baohua Dongnuo Biotechnology BHD
Tirzepatide
Tested 5 Samples
Last test 20 Feb 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Baohua Dongnuo Biotechnology BHD

Samples are tested in commercial labs

Tests Count

5

Scores

AVG7.0MIN5.8MAX8.0

Last

20 Feb 2026

First

11 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
20 Feb 2026View6.360mg54.5mg-9.2%99.72%(no batch ID)No Label / Silver Crimp / Red CapLab EPublic
19 Jan 2026View8.010mg9.75mg-2.5%99.95%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
19 Jan 2026View8.015mg14.9mg-0.7%99.95%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab EPublic
15 Jan 2026View5.820mg22.4mg+12.0%99.80%(no batch ID)No Label / Silver Crimp / Violet CapLab GPublic
11 Aug 2025View7.260mg56.1mg-6.5%99.76%(no batch ID)No Label / Silver Crimp / Clear Red CapLab EPublic
Test my peptides for free